Fortitude Family Office’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.83K Buy
91
+5
+6% +$438 ﹤0.01% 883
2026
Q1
$7.78K Buy
86
+39
+83% +$3.58K ﹤0.01% 748
2025
Q4
$4.23K Sell
47
-11
-19% -$1.04K ﹤0.01% 877
2025
Q3
$5.71K Buy
58
+20
+53% +$1.98K ﹤0.01% 766
2025
Q2
$3.47K Buy
38
+12
+46% +$1.16K ﹤0.01% 939
2025
Q1
$2.94K Hold
26
﹤0.01% 855
2024
Q4
$2.75K Hold
26
﹤0.01% 974
2024
Q3
$2.81K Hold
26
﹤0.01% 938
2024
Q2
$2.82K Hold
26
﹤0.01% 741
2024
Q1
$3.43K Hold
26
﹤0.01% 723
2023
Q4
$3.16K Buy
+26
New +$2.9K ﹤0.01% 805

Other funds holding ZBH

Fortitude Family Office's ZBH Position: Q2 2026 in Review

Fortitude Family Office increased its Zimmer Biomet (ZBH) stake by 5.8% in Q2 2026, buying an estimated $438 and bringing the position to 91 shares worth $7.83K. The position accounts for ﹤0.01% of the portfolio, ranked #883.

Fortitude Family Office first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Fortitude Family Office held 91 shares of Zimmer Biomet worth $7.83K as of Q2 2026.
  • Fortitude Family Office bought 5 Zimmer Biomet shares in Q2 2026, an estimated $438.
  • Zimmer Biomet made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #883 holding.
  • Fortitude Family Office first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.